Rangarao Sai 4/A

4/A · Pelthos Therapeutics Inc. · Filed Apr 1, 2026

AI-generated summary of this filing

Updated Apr 1, 2026

Pelthos (PTHS) CCO Rangarao Sai Receives Award of 30,518 RSUs

What Happened

Rangarao Sai, Chief Commercial Officer of Pelthos Therapeutics (PTHS), was granted 30,518 restricted stock units (RSUs) on 2025-07-02. The RSUs were granted at $0.00 (no cash paid) and are reported as an award/grant (transaction code A). This filing is an amendment that moves the original disclosure into Table I of the Form 4.

Key Details

Transaction date: 2025-07-02; amended Form 4 filed: 2026-04-01.
Grant size: 30,518 RSUs; reported acquisition price: $0.00; economic value at grant: $0 (face amount reported).
Vesting: 1/3 vests on July 2, 2026; remaining 2/3 vest in equal quarterly installments over the following two years, contingent on continued service.
Settlement: RSUs may be settled solely in shares of common stock (one RSU = one share upon settlement).
Footnote: Original grant was reported in Table II of the prior Form 4; this amendment reports it in Table I (administrative reporting change).
Shares owned following the transaction are not specified in this amendment.
Exhibit included: Exhibit 24 (Power of Attorney).

Context

This was a compensation grant to an officer, not an open-market purchase or sale; such awards are routine for employee retention and do not by themselves indicate a buy/sell signal. The RSUs vest over time, so any future sales or ownership changes will depend on vesting and potential tax-withholding arrangements.

Form 4/AAmended

Period: 2025-07-02

Chief Commercial Officer

Transactions

Footnotes (2)

[F1]Represents shares of common stock, par value $0.0001 per share ("Common Stock") of Pelthos Therapeutics Inc. (the "Issuer"), issuable upon settlement of restricted stock units of the Issuer ("RSUs") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the "2023 Plan"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4 filed by the reporting person (the "Original Form 4"). This Form 4 amendment (this "Amendment") is being filed to amend the Original Form 4 in order to report the grant of such RSUs in Table I.
[F2]The RSUs were received as compensation for the reporting person's service as an officer of the Issuer pursuant to the 2023 Plan. The RSUs vest as follows: the initial one-third of such shares vests on July 2, 2026, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two years, so long as the reporting person remains in the service of the Issuer on each such anniversary.

Signature

/s/ Francis Knuettel II, by power of attorney|2026-04-01

2 files